Predicting chemotherapy-induced thrombocytopenia in cancer patients with solid tumors or lymphoma.

Abolfazl RazzaghdoustBahram MofidMasoumeh Zangeneh

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2019)

We developed a predictive model for chemotherapy-induced thrombocytopenia based on readily available and easily assessable clinical and laboratory factors. This study may provide a valuable insight to guide optimized treatment of cancer patients. Further studies with larger sample size are warranted.

Keyphrases

chemotherapy induced
diffuse large b cell lymphoma
case control
replacement therapy
combination therapy
smoking cessation